Atypicals, Spirochetes, MycobacteriaMarch 26, 20265 min read

Q-Bank Breakdown: Chlamydia trachomatis — Why Every Answer Choice Matters

Clinical vignette on Chlamydia trachomatis. Explain correct answer, then systematically address each distractor. Tag: Microbiology > Atypicals, Spirochetes, Mycobacteria.

You’re cruising through a micro q-bank when you hit a deceptively “simple” STI question—and suddenly every option looks plausible. That’s not an accident: Chlamydia trachomatis questions are designed to test whether you can separate intracellular bugs, atypicals, spirochetes, and acid-fast organisms under time pressure. Let’s walk through a classic vignette, then dismantle every distractor like you would on test day.


Clinical Vignette (Q-bank style)

A 22-year-old sexually active woman presents with 5 days of dysuria and increased urinary frequency. She denies flank pain and fever. She also notes a new mucopurulent vaginal discharge. Urinalysis shows pyuria but no bacteria are seen on Gram stain. A nucleic acid amplification test (NAAT) is positive for an obligate intracellular organism that lacks a classic peptidoglycan cell wall.

Which of the following is the most appropriate treatment?

A. Ceftriaxone
B. Doxycycline
C. Metronidazole
D. Penicillin G
E. Rifampin


The Correct Answer: B. Doxycycline

This is Chlamydia trachomatis causing urethritis/cervicitis.

Why the vignette screams Chlamydia

  • Dysuria + frequency + pyuria but no organisms on Gram stain
    • Think: “sterile pyuria” → common in Chlamydia urethritis
  • Mucopurulent cervicitis (often minimal exam findings)
  • NAAT positive (the preferred test)

High-yield treatment

  • Uncomplicated genital Chlamydia:
    • Doxycycline (first-line)
    • Alternative: Azithromycin (often used if adherence is a concern; also commonly tested historically)

Must-know Step points

  • Treat partners and advise abstinence until therapy completed.
  • Screening: sexually active women <25 and older women at risk.
  • Complications:
    • PID → infertility, ectopic pregnancy, chronic pelvic pain
    • Neonatal conjunctivitis/pneumonia (afebrile, staccato cough)
    • Reactive arthritis (can show up as a “what else is associated?” distractor)

Rapid Micro Review: What makes Chlamydia “atypical”?

Chlamydia trachomatis

  • Obligate intracellular
  • No classic peptidoglycan cell wall
    • So beta-lactams are not reliable
  • Biphasic life cycle
    • Elementary body = infectious form (enters cell)
    • Reticulate body = replicative form (inside cell)
  • Diagnosed with NAAT (not culture in routine practice)

Now, Why Every Other Answer Choice Is Wrong (and what it would treat)

A. Ceftriaxone — tempting, but incomplete here

Why it’s wrong for this question:
Ceftriaxone targets Neisseria gonorrhoeae, not Chlamydia. The vignette leans Chlamydia via sterile pyuria and intracellular organism lacking classic peptidoglycan.

When ceftriaxone is right (know this cold):

  • Gonorrhea (Gram-negative intracellular diplococci)
    • Urethritis/cervicitis with PMNs and kidney-shaped diplococci on Gram stain (men more reliable)
  • Disseminated gonococcal infection: dermatitis, tenosynovitis, migratory polyarthritis

Step trap:
If the stem suggests STI but isn’t definitive, real-world empiric therapy often covers both (ceftriaxone + doxycycline). But boards will ask what best treats the organism described.


C. Metronidazole — anaerobes/protozoa, not Chlamydia

Why it’s wrong:
Metronidazole treats anaerobes and certain protozoa; it doesn’t cover Chlamydia.

When metronidazole is right:

  • Trichomonas vaginalis
    • Frothy yellow-green discharge, “strawberry cervix,” motile trichomonads
  • Bacterial vaginosis (Gardnerella)
    • Clue cells, fishy odor, thin gray discharge
  • C. difficile
  • Anaerobic infections “below the diaphragm” (classic heuristic)

High-yield mechanism/tox:

  • Generates free radicals that damage DNA in anaerobes
  • Disulfiram-like reaction, metallic taste

D. Penicillin G — think spirochetes (and some Gram+), not Chlamydia

Why it’s wrong:
Chlamydia lacks a classic peptidoglycan cell wall → beta-lactams like penicillin are not dependable.

When penicillin G is right:

  • Treponema pallidum (syphilis) — a key spirochete in this content bucket
    • Primary: painless chancre
    • Secondary: rash on palms/soles, condylomata lata
    • Tertiary: gummas, aortitis, neurosyphilis
    • Congenital: snuffles, Hutchinson teeth, saber shins
  • Some Gram positives (e.g., Strep pyogenes in select contexts)

Board-relevant clue:
Syphilis is diagnosed with serology (RPR/VDRL, confirm with FTA-ABS/TP-PA), not NAAT for an intracellular organism.


E. Rifampin — mycobacteria and prophylaxis; not first-line here

Why it’s wrong:
Rifampin is a cornerstone drug for Mycobacterium tuberculosis (acid-fast organisms) and some prophylaxis indications—not uncomplicated Chlamydia cervicitis/urethritis.

When rifampin is right:

  • TB treatment (RIPE: Rifampin, Isoniazid, Pyrazinamide, Ethambutol)
  • MAC regimens (with macrolides, etc.)
  • Prophylaxis:
    • Close contacts of Neisseria meningitidis
    • H. influenzae type b prophylaxis in select settings

High-yield mechanism/tox:

  • Inhibits DNA-dependent RNA polymerase
  • CYP450 inducer
  • Orange body fluids (tears/urine)

Quick “Atypicals vs Spirochetes vs Mycobacteria” Sorting Table

BucketHallmarkClassic ClueExample(s)First-line treatment (Step-level)
Atypicals (intracellular/no classic wall)Don’t behave like typical Gram+/-Negative Gram stain despite infectionChlamydia, Mycoplasma, LegionellaDoxycycline/azithro (organism-dependent)
SpirochetesCorkscrew motilityPainless chancre, rash palms/soles (syphilis)Treponema, Borrelia, LeptospiraPenicillin G (syphilis)
MycobacteriaAcid-fast (mycolic acids)Cavitary lung lesions, night sweats; AFB stainM. tuberculosis, MACRIPE for TB (rifampin included)

High-Yield Chlamydia Associations You’ll Actually See in Questions

Chlamydia trachomatis serovars (Step 1/2 favorite)

  • A–C: Trachoma (chronic conjunctivitis → blindness)
  • D–K: Urethritis/cervicitis, PID, neonatal conjunctivitis/pneumonia
  • L1–L3: Lymphogranuloma venereum (LGV)
    • Painful inguinal lymphadenopathy/buboes, proctocolitis (especially in MSM)

“Sterile pyuria” differential (high-yield)

If UA shows WBCs but culture/Gram stain is negative:

  • Chlamydia urethritis (very common)
  • TB (genitourinary TB—less common but classic)
  • Nephrolithiasis/interstitial nephritis (noninfectious considerations)

Takeaway: How to win these questions fast

When you see:

  • Pyuria + negative Gram stain, mucopurulent discharge
  • NAAT positive for intracellular organism
  • Mention of no classic peptidoglycan

Lock in: Chlamydia trachomatis → doxycycline (or azithro). Then eliminate distractors by category:

  • Ceftriaxone = gonorrhea
  • Metronidazole = trich/BV/anaerobes
  • Penicillin G = spirochetes (syphilis)
  • Rifampin = mycobacteria/meningococcal prophylaxis